NovoTHOR

Name

NovoTHOR

Legal name

THOR Photomedicine Limited

Website

https://novothor.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Medical Light Therapy Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Infrared Therapy (Infrared Sauna & Light Therapy) (HSADAKAG)

akta.pro secondary industries

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)

Keywords

• Red light therapy
• Photobiomodulation devices
• Whole body light therapy
• Medical LED devices
• Near infrared therapy

Headquarters

HQ city

Amersham

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. NovoTHOR Light Therapy Bed Sales: Sale of the NovoTHOR full body red light therapy bed - a high-end medical device priced as a capital equipment purchase for clinics, sports facilities, and wellness centers. The company manufactures in the USA and offers 5-year warranty.
2. Service and Maintenance: The company offers service and maintenance for NovoTHOR devices. They provide service bookings through their website.
3. Training Courses: THOR offers training courses for doctors, nurses, and clinicians on photobiomodulation mechanisms. These are considered the best in the world according to company materials.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels11 records

Core offering

NovoTHOR designs, manufactures, and sells full body red and near-infrared light therapy beds that use photobiomodulation (660nm red and 850nm near-infrared wavelengths delivered through narrow-band LEDs) for temporary relief of minor muscle and joint pain, muscle spasm, arthritis pain, stiffness, increased local blood circulation, and muscle relaxation. The company sells these medical devices (standard NovoTHOR and NovoTHOR XL variants) as capital equipment to elite sports organizations, military forces, healthcare providers, and wellness facilities, complemented by service/maintenance contracts and clinical training courses.

Product overview

NovoTHOR offers a portfolio of two full body red light therapy bed products: the standard NovoTHOR and the larger NovoTHOR XL variant. Both products utilize photobiomodulation technology with switchable red (660nm) and near-infrared (850nm) wavelengths delivered through high-performance narrow-band LEDs. The devices are designed for temporary relief of minor muscle and joint pain, arthritis pain, muscle spasms, increased local blood circulation, and muscle relaxation. The standard NovoTHOR provides 2,400W TDP while the XL variant delivers 2,700W TDP. Both models are approved or cleared as medical devices in over 30 countries and are manufactured in the USA to medical device standards.

Differentiator

Problem solved

Functional benefit

Products and services

• NovoTHOR Full Body Red Light Therapy Bed The NovoTHOR is a full body red and near-infrared light therapy bed delivering switchable 660nm red and 850nm near-infrared wavelengths via narrow-band LEDs at 2,400W TDP. It provides temporary relief of minor muscle and joint pain and stiffness, minor arthritis pain and muscle spasm, temporary increase in local blood circulation, and temporary muscle relaxation. It is sold as CE-marked, GMP-manufactured capital equipment (with a 5-year warranty) to elite sports organizations, military forces, healthcare providers, pain clinics, and wellness facilities, and is cleared as a medical device in over 30 countries.
• NovoTHOR XL Full Body Red Light Therapy Bed The NovoTHOR XL is the larger variant of NovoTHOR's full body red light therapy bed, providing 2,700W TDP power output, 94-inch length and 521 lbs weight, with the same dual 660nm red and 850nm near-infrared wavelength capability as the standard NovoTHOR. It targets institutional buyers (sports facilities, military, and healthcare providers) needing the larger treatment area and higher output.
• NovoTHOR Service and Maintenance Service and maintenance offering for NovoTHOR and NovoTHOR XL devices, booked through the NovoTHOR website and supported by THOR engineers to keep equipment operating to specification across its service life (devices built over a decade ago remain in use).
• THOR Photobiomodulation Training Courses Training courses offered by THOR for doctors, nurses, and clinicians covering photobiomodulation mechanisms and dosing parameters, described as the best such courses in the world by company materials, to drive clinical adoption and proper use of NovoTHOR and related THOR products.

Quantifiable outcome

• 5 independent clinical studies published confirming effectiveness
• +4 more outcomes

Named customers19 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Eight partnerships are on record, tiered core.

• US CongresscoreStrategic or Co-development Partner · 11 October 2018CEO James Carroll briefed the United States Congress on photobiomodulation as a pain management tool to address the opioid crisis. This occurred October 11, 2018 at the Rayburn Building, Washington D.C. The briefing was to the House Committee on Space, Science & Technology.
• Harvard Medical SchoolcoreStrategic or Co-development PartnerHarvard Medical School researchers collaborate with THOR on photobiomodulation mechanisms and treatment parameters. Dr. Michael Hamblin from Harvard Medical School has publicly endorsed CEO James Carroll as an expert on photobiomodulation literature. THOR has collaborated with 6 Harvard Medical research groups and contributed to research published in Harvard-reviewed publications.
• St. Jude Children's Research HospitalcoreStrategic or Co-development PartnerSt. Jude Children's Research Hospital consults THOR on photobiomodulation mechanisms and treatment parameters for pediatric applications.
• MIT (Massachusetts Institute of Technology)coreStrategic or Co-development PartnerMIT researchers consult THOR on mechanisms and treatment parameters for light therapy applications.
• US MilitarycoreStrategic or Co-development PartnerUS Military forces (Army Special Forces, Navy SEALs, Navy, Air Force) use NovoTHOR to increase operational readiness through performance enhancement, injury prevention, and improved recovery. THOR has collaborated with US Military on multiple research publications cited in PubMed. Military use case is prominently featured in marketing materials.
• United NationscoreStrategic or Co-development PartnerCEO James Carroll addressed the United Nations Global Health Impact Forum about the uses of Photobiomodulation, positioning light therapy as a non-pharmaceutical pain management solution.
• 50 Academic Institutions GloballycoreStrategic or Co-development PartnerTHOR has contributed to 51 academic papers and collaborated with 50 academic institutions globally. Partners include not-for-profit organisations and government institutions working to make Light Therapy reimbursable in the US.
• Professional Sports OrganizationscoreGTM or Marketing PartnerProfessional sports teams including NFL (Buffalo Bills, Arizona Cardinals, Carolina Panthers, Detroit Lions, Washington Commanders), NBA (Indiana Pacers, LA Clippers, Phoenix Suns, Toronto Raptors, Utah Jazz), college athletics (North Dakota Hawks, Ohio State), and Olympic athletes use NovoTHOR. Half of NBA 2024 playoff semi-finalists use NovoTHOR.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Celluma: Medical-grade LED light therapy devices for professional use in dermatology, aesthetics, and pain management. Competes with NovoTHOR in clinical-channel photobiomodulation with FDA-cleared indications.
• Red Light Rising: UK-based peer selling red and near-infrared light therapy panels. Direct geographic overlap with NovoTHOR's UK headquarters and comparable product offering in the photobiomodulation device category.
• Joovv: Direct competitor in the red light therapy device market, offering modular full-body and large-panel LED systems for home, clinical, and athletic use. Overlaps closely with NovoTHOR on core photobiomodulation technology, target customers (athletes, wellness consumers, clinics), and wavelengths (660nm red and 850nm near-infrared).
• Mito Red Light: Direct peer offering red and near-infrared light therapy panels targeting consumers, athletes, and clinicians. Competes with NovoTHOR in the PBM category with similar wavelengths and a comparable premium positioning strategy.
• LightStim: Manufactures FDA-cleared LED light therapy devices for skincare, pain relief, and wellness. Comparable to NovoTHOR in clinical-channel positioning and therapeutic light-based medical device category.

Emerging players

• Sun Home Saunas: Infrared sauna and full-spectrum light therapy brand. Adjacent competitor in the infrared therapy consumer market with overlapping whole-body wellness use cases but different core delivery mechanism.
• HigherDOSE: Infrared sauna and red light therapy brand targeting the consumer wellness and longevity segment. Adjacent to NovoTHOR with overlapping infrared light therapy technology but consumer rather than medical-device positioning.
• PlatinumLED Therapy Lights: Sells red and near-infrared light therapy panels for home and clinical use. Competes with NovoTHOR in the PBM category with comparable wavelengths but smaller form factors and a price-led positioning.

Broad incumbents

• Multi Radiance Medical: Medical device manufacturer of therapeutic super pulsed laser and light therapy devices for pain management and rehabilitation. Comparable to NovoTHOR in clinical and rehabilitation use cases for photobiomodulation.
• LiteCure (LiteCure Medical): Established medical device company offering Class IV laser therapy and LED light therapy systems for physical therapy, chiropractic, and veterinary markets. Comparable to NovoTHOR in clinical-channel photobiomodulation and therapeutic dosing focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/novothor
• YouTubeyoutube.com/channel/UCjVSl0Jf1Y0B7_D2Qe8qVEg
• Facebookfacebook.com/NovoTHORpod
• Instagraminstagram.com/novothor
• LinkedInlinkedin.com/company/novothor

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NovoTHOR